FDA Inspection 1179980 — University of Chicago Hospitals

University of Chicago Hospitals — FEI 3003966339

The FDA completed an inspection of University of Chicago Hospitals on September 7, 2022 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 7, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Chicago, IL (United States)